Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T13:36:31.237Z.
Calculation as of: 2026-10-06T13:36:31.237Z.
Quote observation: 2026-10-06T13:34:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Electra Therapeutics Inc.
Market Cap
$202.16M
EV/Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$198.09M
EV/Assets Ratio
1.88x
TTM Avg
1.09x
3Y Avg
0.82x
5Y Avg
1.07x
Market Cap
$194.51M
EV/Assets Ratio
1.49x
TTM Avg
1.88x
3Y Avg
1.36x
5Y Avg
1.36x
Market Cap
$184.12M
EV/Assets Ratio
1.87x
TTM Avg
2.04x
3Y Avg
1.69x
5Y Avg
1.19x
Market Cap
$180.08M
EV/Assets Ratio
0.25x
TTM Avg
1.34x
3Y Avg
1.51x
5Y Avg
4.94x
Market Cap
$177.91M
EV/Assets Ratio
5.51x
TTM Avg
2.45x
3Y Avg
1.55x
5Y Avg
1.57x
Market Cap
$175.27M
EV/Assets Ratio
0.93x
TTM Avg
0.59x
3Y Avg
0.53x
5Y Avg
0.68x
Market Cap
$230.09M
EV/Assets Ratio
N/A
TTM Avg
0.12x
3Y Avg
2.06x
5Y Avg
2.72x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $202.16M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $198.09M | 1.88x | 1.09x | 0.82x | 1.07x |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $194.51M | 1.49x | 1.88x | 1.36x | 1.36x |
| Compugen Ltd. (CGEN)vs › | $219.84M | 1.54x | 1.42x | 1.29x | 1.26x |
| Journey Medical Corporation (DERM)vs › | $184.12M | 1.87x | 2.04x | 1.69x | 1.19x |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.08M | 0.25x | 1.34x | 1.51x | 4.94x |
| Cue Biopharma, Inc. (CUE)vs › | $177.91M | 5.51x | 2.45x | 1.55x | 1.57x |
| Precision BioSciences, Inc. (DTIL)vs › | $175.27M | 0.93x | 0.59x | 0.53x | 0.68x |
| Keros Therapeutics, Inc. (KROS)vs › | $230.09M | N/A | 0.12x | 2.06x | 2.72x |
| Alector, Inc. (ALEC)vs › | $232.03M | 1.01x | 0.64x | 0.61x | 0.75x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
